BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30269324)

  • 1. [Establishment and preliminary application of tissue response grading system following neoadjuvant chemotherapy].
    Yang K; Zhang W; Chen X; Chen X; Liu K; Zhao L; Liu J; Wu B; Zhou Z; Hu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1032-1038. PubMed ID: 30269324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the relationship between tumor regression grade and lymph node regression grade].
    Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
    Morifuji M; Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Sueda T
    Gan To Kagaku Ryoho; 2003 May; 30(5):711-5. PubMed ID: 12795108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.
    Wu ZM; Teng RY; Shen JG; Xie SD; Xu CY; Wang LB
    J Int Med Res; 2011; 39(6):2086-95. PubMed ID: 22289523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
    Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.
    Chen Y; Chen X; Lin Y; Zhang S; Zhou Z; Peng J
    BMC Cancer; 2024 Feb; 24(1):255. PubMed ID: 38395845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
    Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
    Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Gastric Cancer Responding to Neoadjuvant Chemotherapy Leading to Histological Change to Grade 3].
    Osakabe H; Katayanagi S; Makuuchi Y; Shigoka M; Sumi T; Tsuchida A; Kawachi S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2228-2230. PubMed ID: 28133278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study.
    Yang H; Zhang WH; Ge R; Peng BQ; Chen XZ; Yang K; Liu K; Chen XL; He D; Liu JP; Zhang WW; Qin Y; Zhou ZG; Hu JK
    Front Oncol; 2021; 11():585006. PubMed ID: 34900661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of carbon nanoparticles labeled node staining in D2 radical resection of gastric cancer with neoadjuvant chemotherapy].
    Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Han GS; Zhao YZ
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3319-3322. PubMed ID: 33202494
    [No Abstract]   [Full Text] [Related]  

  • 13. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
    Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.
    Bélanger J; Soucy G; Sidéris L; Leblanc G; Drolet P; Mitchell A; Leclerc YE; Beaudet J; Dufresne MP; Dubé P
    J Am Coll Surg; 2008 Apr; 206(4):704-8. PubMed ID: 18387477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.
    Kinoshita O; Ichikawa D; Ichijo Y; Komatsu S; Okamoto K; Kishimoto M; Yanagisawa A; Otsuji E
    World J Gastroenterol; 2015 Dec; 21(48):13500-6. PubMed ID: 26730161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy].
    Shioiri T; Inoue S; Kusano T; Umekita N; Kitamura M; Warabi M; Kawahara Y
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1327-30. PubMed ID: 16184934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
    Fleischmann A; Thalmann GN; Perren A; Seiler R
    Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
    Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
    Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.